Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


Formulation and pharmacokinetic evaluation of solid lipid nanoparticles containing an antipsychotic agent for improved oral delivery

  • In: Posters D - Formulation Design and Pharmaceutical Technology
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Poster
  • Poster code: PD-059
  • By: NATARAJAN, Jawahar (Jss college of pharmacy, Pharmaceutics, Ootacamund, India)
  • Co-author(s): Meyyanathan (Jss college of pharmacy, Ootcamund, India)
    Jubie (Jss college of pharmacy, Ootacamund, India)
    Dhanabal (Jss college of pharmacy, Ootacamund, India)
  • Abstract:

    Background: Olanzapine is a psychotropic agent that belongs to the thioenobenzodiazepine class and is indicated for acute and maintenance treatment of schizophrenia. The conventional formulations of olanzapine suffer from low bioavailability (40%) and wide variety of side effects are associated with current dosage forms of the drug. It is..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses